Latest News

PerkinElmer provides newborn screening assay for PPMD’s New York State pilot program

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it is providing the newborn screening assay for Parent Project Muscular Dystrophy’s Newborn Screening Pilot for Duchenne Muscular Dystrophy (Duchenne).

Source link

Related posts

OrthoXel receives FDA 510(k) clearance for femoral nailing system


Systematic classification of the His-Me finger superfamily


Many elderly patients with metastatic renal cell carcinoma benefit from targeted therapies


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy